Skip to main content
. 2024 Nov 11;29(5):4705–4725. doi: 10.1007/s11030-024-11023-3

Table 2.

Cytotoxic activity of compound 5b and doxorubicin against MCF-7 breast cancer cell line under normal conditions

Compound IC50 (µM) ± SD
5b 5.21 ± 0.21
Doxorubicin 11.58 ± 0.46